First Mercantile Trust’s Travere Therapeutics TVTX Stock Holding History

First Mercantile Trust’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,966	Closed	-$72K	–	957
2020 Q1	$72K	Buy	4,966 +223	+5%	+$3.35K	0.01%	633
2019 Q4	$67K	Sell	4,743 -79	-2%	-$1.01K	0.01%	759
2019 Q3	$56K	Buy	4,822 +320	+7%	+$5.29K	0.01%	802
2019 Q2	$90K	Sell	4,502 -63	-1%	-$1.24K	0.01%	671
2019 Q1	$103K	Buy	4,565 +55	+1%	+$1.22K	0.02%	653
2018 Q4	$102K	Buy	4,510 +310	+7%	+$7.71K	0.02%	648
2018 Q3	$121K	Sell	4,200 -240	-5%	-$6.86K	0.02%	655
2018 Q2	$121K	Buy	4,440 +210	+5%	+$5.59K	0.02%	665
2018 Q1	$95K	Hold	4,230	–	–	0.02%	692
2017 Q4	$89K	Sell	4,230 -590	-12%	-$13.5K	0.02%	730
2017 Q3	$120K	Buy	4,820 +360	+8%	+$7.93K	0.02%	677
2017 Q2	$86K	Buy	4,460 +80	+2%	+$1.45K	0.02%	753
2017 Q1	$81K	Sell	4,380 -260	-6%	-$5.09K	0.01%	763
2016 Q4	$88K	Buy	4,640 +50	+1%	+$1.02K	0.01%	766
2016 Q3	$103K	Sell	4,590 -1,340	-23%	-$25.5K	0.01%	721
2016 Q2	$106K	Buy	5,930 +1,550	+35%	+$25.1K	0.01%	719
2016 Q1	$60K	Sell	4,380 -140	-3%	-$2.12K	0.01%	816
2015 Q4	$87K	Buy	4,520 +1,370	+43%	+$27.4K	0.01%	846
2015 Q3	$64K	Buy	3,150 +810	+35%	+$24K	0.01%	898
2015 Q2	$78K	Buy	+2,340	New	+$64.1K	0.01%	905

Other funds holding TVTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

First Mercantile Trust's TVTX Position: Q2 2020 in Review

First Mercantile Trust sold out of Travere Therapeutics (TVTX) in Q2 2020, closing a stake of 4,966 shares — an estimated $72K sold.

First Mercantile Trust first reported a position in TVTX in Q2 2015 and held it in 20 quarters. The position peaked at $121K in Q3 2018. 147 funds tracked by Wall St. Rank hold TVTX as of Q2 2020.

First Mercantile Trust reported no remaining Travere Therapeutics position as of Q2 2020 after selling out during the quarter.
First Mercantile Trust sold 4,966 Travere Therapeutics shares in Q2 2020, an estimated $72K.
First Mercantile Trust first reported a position in Travere Therapeutics in Q2 2015 and held it in 20 quarters.
First Mercantile Trust's Travere Therapeutics position peaked at $121K in Q3 2018.
147 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2020.

Based on First Mercantile Trust's 13F filing for Q2 2020, filed 10 Aug 2020.